Search - tctmd.com

Displaying 1 - 14 of 14

Sort: Relevancy | Date

News Conference News TCT 2024

After TAVI, Single Antiplatelet Better Than Dual: TRITAVI Registry

Yael L. Maxwell

November 05, 2024

News Conference News TCT 2023

Durability, Hemodynamics Look Good for SAVR, TAVI in PARTNER 3

Michael O'Riordan

November 01, 2023

News Conference News TCT 2023

WATCH-TAVR: Adding LAAO to TAVI No Worse Than TAVI Alone

Todd Neale

October 24, 2023

News Conference News TCT 2022

As Time Goes By, Post-TAVI Thrombus Becomes More OAC Resistant

Michael O'Riordan

September 18, 2022

News Conference News TCT 2020

Valve Disease Plus COVID-19 Often a Lethal Combination, Registry Shows

Caitlin E. Cox

October 14, 2020

News Conference News TCT 2019

Oral Anticoagulation After TAVR Doesn’t Reduce Ischemic Cerebral Lesions: AUREA

Michael O'Riordan

September 28, 2019

News Conference News TCT 2019

Leaflet Thickening and Impaired Motion No Worse With TAVR: PARTNER 3 CT

Michael O'Riordan

September 27, 2019

News Opinion Editor's Corner TCT 2019

TCT 2019 Day Two: Transcatheter Valves, New and Old

Shelley Wood

September 27, 2019

News Daily News TCT 2018

High Mortality but Durable Results With Valve-in-Valve TAVR

Michael O'Riordan

September 23, 2018

News Conference News TCT 2017

A-fib Signals Worse Prognosis After Aortic Valve Replacement in Intermediate-Risk Patients

Todd Neale

November 08, 2017

News Conference News TCT 2017

One in Six Patients With LBBB Post-TAVR Develop Atrioventricular Block

Michael O'Riordan

October 31, 2017

News Conference News TCT 2015

BRAVO 3: Bivalirudin Similar to Heparin in Transfemoral TAVR

Yael L. Maxwell

October 15, 2015

Presentation TCT 2013

Anticoagulation and Antiplatelet Regimens After TAVR: Bivalirudin (BRAVO 2/3 Trial) and Other Alternatives

Presenter: George Dangas

October 28, 2013

Presentation TCT 2012

TCT-82. Cost-effectiveness Of Transcatheter Left Atrial Appendage Occlusion Compared with 5 Alternative Anticoagulation Strategies for Stroke Prevention in Atrial...

Presenter: Bryan Yan

October 23, 2012

Advertisement

After TAVI, Single Antiplatelet Better Than Dual: TRITAVI Registry

Durability, Hemodynamics Look Good for SAVR, TAVI in PARTNER 3

WATCH-TAVR: Adding LAAO to TAVI No Worse Than TAVI Alone

As Time Goes By, Post-TAVI Thrombus Becomes More OAC Resistant

Valve Disease Plus COVID-19 Often a Lethal Combination, Registry Shows

Oral Anticoagulation After TAVR Doesn’t Reduce Ischemic Cerebral Lesions: AUREA

Leaflet Thickening and Impaired Motion No Worse With TAVR: PARTNER 3 CT

TCT 2019 Day Two: Transcatheter Valves, New and Old

High Mortality but Durable Results With Valve-in-Valve TAVR

A-fib Signals Worse Prognosis After Aortic Valve Replacement in Intermediate-Risk Patients

One in Six Patients With LBBB Post-TAVR Develop Atrioventricular Block

BRAVO 3: Bivalirudin Similar to Heparin in Transfemoral TAVR

Anticoagulation and Antiplatelet Regimens After TAVR: Bivalirudin (BRAVO 2/3 Trial) and Other Alternatives

TCT-82. Cost-effectiveness Of Transcatheter Left Atrial Appendage Occlusion Compared with 5 Alternative Anticoagulation Strategies for Stroke Prevention in Atrial...

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content